Shenzhen Weiguang Biological Products Co Ltd Financial Flexibility Index
Shenzhen Weiguang Biological Products Co Ltd financial flexibility index. Shenzhen Weiguang Biological Products Co Ltd (002880) has a Financial Flexibility Index of 0.13x as of September 2025. Free cash flow of CN¥133.85 Million (operating CF CN¥51.60 Million minus capex CN¥82.24 Million) represents 0% of total liabilities (CN¥1.04 Billion). Explore 002880 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shenzhen Weiguang Biological Products Co Ltd (2012–2025)
Financial flexibility index of Shenzhen Weiguang Biological Products Co Ltd from 2012 to 2025. Historical Financial Flexibility Index trend for Shenzhen Weiguang Biological Products Co Ltd across 14 annual periods. Check 002880 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Shenzhen Weiguang Biological Products Co Ltd Financial Flexibility Index by Year (2012–2025)
Shenzhen Weiguang Biological Products Co Ltd financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Shenzhen Weiguang Biological Products Co Ltd. For the full cash flow conversion analysis, see Shenzhen Weiguang Biological Products Co cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.33x | CN¥432.87 Million | CN¥263.18 Million | CN¥1.29 Billion | ▼ -18.7% |
| 2024 | 0.41x | CN¥433.27 Million | CN¥177.77 Million | CN¥1.05 Billion | ▼ -53.0% |
| 2023 | 0.87x | CN¥726.79 Million | CN¥397.94 Million | CN¥831.14 Million | ▲ +88.5% |
| 2022 | 0.46x | CN¥328.57 Million | CN¥1.20 Million | CN¥708.20 Million | ▼ -79.5% |
| 2021 | 2.27x | CN¥487.71 Million | CN¥246.89 Million | CN¥215.23 Million | ▼ -2.4% |
| 2020 | 2.32x | CN¥493.15 Million | CN¥303.96 Million | CN¥212.36 Million | ▲ +20.4% |
| 2019 | 1.93x | CN¥263.49 Million | CN¥185.70 Million | CN¥136.64 Million | ▲ +60.9% |
| 2018 | 1.20x | CN¥184.05 Million | CN¥99.54 Million | CN¥153.53 Million | ▲ +128.5% |
| 2017 | 0.52x | CN¥89.98 Million | CN¥28.61 Million | CN¥171.52 Million | ▲ +13.6% |
| 2016 | 0.46x | CN¥186.32 Million | CN¥126.41 Million | CN¥403.44 Million | ▼ -9.5% |
| 2015 | 0.51x | CN¥235.95 Million | CN¥150.09 Million | CN¥462.25 Million | ▲ +36.3% |
| 2014 | 0.37x | CN¥172.54 Million | CN¥134.17 Million | CN¥460.73 Million | ▲ +135.2% |
| 2013 | 0.16x | CN¥77.86 Million | CN¥20.93 Million | CN¥488.91 Million | ▼ -70.7% |
| 2012 | 0.54x | CN¥288.83 Million | CN¥115.88 Million | CN¥530.63 Million | — |